AvidBiotics Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AvidBiotics Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10893
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AvidBiotics Corp (AvidBiotics) is a pharmaceutical company that develops non-antibody therapeutic proteins targeting cancer cells, virus-infected cells and pathogenic bacteria. The company develops a portfolio of therapeutic protein candidates and protein engineering platforms which include avidocin proteins, mica-body proteins and purocin proteins. Its avidocin proteins are used in the treatment of antibiotic-resistant bacterial infections and microbiota management diseases. AvidBiotics’ mica-body proteins are used in immune-oncology applications and treatment of viral infections. The company’s therapeutic proteins are designed to destroy target cells with surgical and laser precision. AvidBiotics is headquartered in South San Francisco, California, the US.

AvidBiotics Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AvidBiotics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AvidBiotics Corp, Medical Devices Deals, 2012 to YTD 2018 9
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
AvidBiotics Raises USD0.9 Million in Venture Financing 11
AvidBiotics Raises Additional US$0.25 Million In Venture Financing 12
AvidBiotics Raises USD1.8 Million in Venture Financing 13
Partnerships 14
AvidBiotics Enters Into Research Agreement With Full Spectrum Genetics 14
Licensing Agreements 15
AvidBiotics Enters Into Co-Development Agreement With DuPont Nutrition To Develop Antibacterial Technology For Food Safety 15
AvidBiotics Corp – Key Competitors 16
AvidBiotics Corp – Key Employees 17
AvidBiotics Corp – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Strategy And Business Planning 19
Nov 01, 2017: AvidBiotics Splits into Two Biotechnology Companies Each Developing its Distinct Technology Platform 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
AvidBiotics Corp, Pharmaceuticals & Healthcare, Key Facts 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AvidBiotics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AvidBiotics Corp, Deals By Therapy Area, 2012 to YTD 2018 8
AvidBiotics Corp, Medical Devices Deals, 2012 to YTD 2018 9
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AvidBiotics Raises USD0.9 Million in Venture Financing 11
AvidBiotics Raises Additional US$0.25 Million In Venture Financing 12
AvidBiotics Raises USD1.8 Million in Venture Financing 13
AvidBiotics Enters Into Research Agreement With Full Spectrum Genetics 14
AvidBiotics Enters Into Co-Development Agreement With DuPont Nutrition To Develop Antibacterial Technology For Food Safety 15
AvidBiotics Corp, Key Competitors 16
AvidBiotics Corp, Key Employees 17

List of Figures
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AvidBiotics Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AvidBiotics Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Deloitte Touche Tohmatsu:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Deloitte Touche Tohmatsu Merger …
  • Memorial Sloan Kettering Cancer Center:企業のM&A・提携動向(医療機器分野)
    Summary Memorial Sloan Kettering Cancer Center (MSKCC) is a healthcare service provider that offers cancer treatment, cancer research and cancer education programs. The center conducts research in the therapeutic areas of bone and marrow stem cell transplantation, cancer pathology, cancer therapeuti …
  • Seven Bank, Ltd.:企業の戦略・SWOT・財務分析
    SummarySeven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • Omaxe Ltd:企業の戦略・SWOT・財務情報
    Omaxe Ltd - Strategy, SWOT and Corporate Finance Report Summary Omaxe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Mueller Water Products, Inc. (MWA):企業概要、財務及び戦略的SWOT分析
    Summary Mueller Water Products, Inc. (Mueller Water Products) is a water manufacturer and distributor. The company manufactures and markets products and services used in the transmission and distribution of drinking water and in water treatment facilities. The company offers products such as ductile …
  • Jones Energy, Inc. (JONE):企業概要、財務及び戦略的SWOT分析
    Summary Jones Energy, Inc. (Jones Energy) is an oil and gas company. It focuses on the acquisition, exploration and production of oil and natural gas properties in Oklahoma and Texas. The company, through its wholly owned subsidiary, Jones Energy Holdings, LLC (JEH LLC), holds assets in two distinct …
  • Kepler Weber S.A. (KEPL3):企業概要、財務及び戦略的SWOT分析
    Kepler Weber S.A. (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Alfa-Bank OAO:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Alfa-Bank OAO Mergers and Acqui …
  • SEEK Limited:企業の戦略・SWOT・財務情報
    SEEK Limited - Strategy, SWOT and Corporate Finance Report Summary SEEK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Eolus Vind AB:企業のM&A・提携動向(エネルギー分野)
    Summary Eolus Vind AB (Eolus) is a leading wind farm developer that carries out the development of green field projects, construction and operation of wind power plants. It provides consultancy services in the development, financing and administration, and management of wind farms. The company also …
  • CohBar Inc (COB.U):企業財務及び戦略的SWOT分析
    Summary CohBar Inc (CohBar) is a biotechnology company that focuses on discovering novel Mitochondrial-Derived Peptides (MDPs). Its MDP portfolio includes MOTS-c for regulation of metabolism and therapeutic potential for Type 2 Diabetes mellitus, obesity, fatty liver and cancers; SHLP-6 targeted at …
  • Cybernet Systems Corporation:企業の戦略・SWOT・財務分析
    SummaryCybernet Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • AXA Equitable Life Insurance Company:企業の戦略・SWOT・財務分析
    SummaryAXA Equitable Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • Toyota Industries Corporation:企業の戦略・SWOT・財務情報
    Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Angle Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers …
  • Enzon Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    SummaryEnzon Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Exxaro Resources Limited:企業の戦略・SWOT・財務分析
    SummaryExxaro Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Edgewater Technology, Inc. (EDGW):企業財務及び戦略的SWOT分析
    Summary Edgewater Technology, Inc. (Edgewater) is a technology services company that offers business and information technology consulting services. The company offers classic consulting and product-based consulting services. Its classic consulting services include business improvement roadmaps, bus …
  • ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer an …
  • Spicers Limited (SRS):企業の財務・戦略的SWOT分析
    Spicers Limited (SRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆